Search - tctmd.com

Displaying 1 - 20 of 54

Sort: Relevancy | Date

News Conference News STS 2026

STS Spells Out Training Pathway for Robotic Surgery

Yael L. Maxwell

February 11, 2026

News Conference News TCT 2025

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Yael L. Maxwell

October 27, 2025

News Conference News NY Valves 2025

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Todd Neale

June 27, 2025

News Conference News NY Valves 2025

Long-term Survival Better With TAVI Explant vs Redo: Medicare Data

Yael L. Maxwell

June 26, 2025

News Conference News HVS 2025

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

Yael L. Maxwell

April 21, 2025

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

Presentation TCT 2024

AltaValve TMVR System for Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

Presenter: Tsuyoshi Kaneko

October 29, 2024

Presentation TCT 2024

TCT 945: AltaValve System TMVR for the Treatment of Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

Presenter: Tsuyoshi Kaneko

October 29, 2024

Presentation TCT 2024

Updates on Surgical TAVR Explants: When is Redo SAVR Preferred After Failed TAVR?

Presenter: Tsuyoshi Kaneko

October 28, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

Presentation NY Valves 2024

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

We Need More Data: Current and Future Research Directions

Presenter: Tsuyoshi Kaneko

June 07, 2024

Presentation NY Valves 2024

Pro-TMVR

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

Clinical Conundrums: Multi-Valve Mitral and Tricuspid Disease

Presenter: Tsuyoshi Kaneko

June 05, 2024

Presentation NY Valves 2024

Innovation in TAVR for Pure AR (J Valve)

Presenter: Tsuyoshi Kaneko

June 05, 2024

Another Win for TAVI in Low-to-Intermediate Risk Patients

News Conference News ACC 2024

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

Yael L. Maxwell

April 08, 2024

News Conference News STS 2024

SAVR After Failed TAVI on the Rise, With High Mortality

Yael L. Maxwell

February 05, 2024

News Daily News

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Michael O'Riordan

January 25, 2024

News Daily News

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

Yael L. Maxwell

January 22, 2024

Advertisement

STS Spells Out Training Pathway for Robotic Surgery

Tendyne Safely Reduces MR in Patients With Severe Calcification: SUMMIT-MAC

Prompt TAVI Benefits Asymptomatic AS Patients Regardless of Guideline Indication

Long-term Survival Better With TAVI Explant vs Redo: Medicare Data

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

AltaValve TMVR System for Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

TCT 945: AltaValve System TMVR for the Treatment of Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

Updates on Surgical TAVR Explants: When is Redo SAVR Preferred After Failed TAVR?

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Mid-term Outcomes of Balloon Expandable TAVR for the Treatment of Failed Bioprosthetic Valves in the United States

We Need More Data: Current and Future Research Directions

Pro-TMVR

Why Favor Redo SAVR After a Failed Bioprosthetic AVR?

Clinical Conundrums: Multi-Valve Mitral and Tricuspid Disease

Innovation in TAVR for Pure AR (J Valve)

Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6

SAVR After Failed TAVI on the Rise, With High Mortality

Lower Mortality With M-TEER vs Surgery, but Devil Is in the Details

Socioeconomics Mire Access to All AVR Options for Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content